Pacer Advisors »

Biosante Pharmaceuticals shares owned by Pacer Advisors

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Pacer Advisors from 13F filings

Historical chart of Pacer Advisors investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by Pacer Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by Pacer Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $41k 746 55.14

More positions owned by Pacer Advisors

United States Treas Bills Treasury Bill (Principal)
Abbvie Common Stock - Domestic (ABBV)
Cvs Health Corp Common Stock - Domestic (CVS)
Chevron Corp Common Stock - Domestic (CVX)
Booking Holdings Common Stock - Domestic (BKNG)
3M Common Stock - Domestic (MMM)
D R Horton Common Stock - Domestic (DHI)
Qualcomm Common Stock - Domestic (QCOM)
Gilead Sciences Common Stock - Domestic (GILD)
Bristol-myers Squibb Common Stock - Domestic (BMY)
Exxon Mobil Corp Common Stock - Domestic (XOM)
Lennar Corp Common Stock - Domestic (LEN)
Conocophillips Common Stock - Domestic (COP)
Cisco Sys Common Stock - Domestic (CSCO)
Altria Group Common Stock - Domestic (MO)

View all positions for Pacer Advisors

Top funds holding Biosante Pharmaceuticals

Vanguard Group
Dimensional Fund Advisors
Global Alpha Capital Management
William Blair Investment Management
Kennedy Capital Management
Jpmorgan Chase & Co
Thompson, Siegel, & Walmsley
Citadel Advisors
Charles Schwab Investment Management
Brandywine Global Investment Management
Bank of New York Mellon
Russell Investments
Assenagon Asset Management
Principal Financial Group
WEDGE Capital Management L

View all funds holding Biosante Pharmaceuticals